
Join to View Full Profile
3400 Spruce St15 Penn TowerPhiladelphia, PA 19104
Phone+1 215-662-3914
Are you Dr. Tuveson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. David Tuveson, MD is an oncologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania and New York.
Education & Training
- Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1997 - 2000
- Johns Hopkins University School of MedicineClass of 1994
Certifications & Licensure
- NY State Medical License 2013 - 2026
- PA State Medical License 2003 - 2014
Publications & Presentations
PubMed
- Signal peptide-independent secretion of keratin-19 by pancreatic cancer cells.Philip Moresco, Jonathan P Kastan, Jung-In Yang, Rishvanth Prabakar, Francesca Minicozzi
Biorxiv. 2025-01-20 - 4 citationsMARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer.Olaf Klingbeil, Damianos Skopelitis, Claudia Tonelli, Toyoki Yoshimoto, Aktan Alpsoy
Cancer Discovery. 2024-12-02 - The evolving role for surgery in pancreatic cancer.David Tuveson, Peter Allen
Carcinogenesis. 2024-11-22
Authored Content
- Successful Creation of Pancreatic Cancer Organoids by Means of EUS-Guided Fine-NeedleJanuary 2018
Press Mentions
- Targeting FGFR2 May Prevent or Delay Some KRAS-Mutated Pancreatic CancersApril 2nd, 2025
- AACR Patient Advocate Forum: Patient-Centric Cancer Clinical Trial DesignFebruary 6th, 2025
- How Pancreatic Cancer Can Be Accelerated by a Splicing-Regulator ProteinApril 27th, 2023
- Join now to see all
Grant Support
- Fibroblast Heterogeneity in Pancreatic CancerCOLD SPRING HARBOR LABORATORY2021–2026
- CSHL Cancer Center Support GrantCOLD SPRING HARBOR LABORATORY1997–2026